Dexamethasone hapten and its preparation method and application
A technology of dexamethasone and hapten, which is applied in the field of hapten and its preparation, can solve problems such as harm, and achieve the effects of convenient use, low detection cost and accurate detection method
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0019] Embodiment 1: Synthesis and identification of dexamethasone hapten (synthetic route such as figure 1 )
[0020] Dissolve 0.80g of dexamethasone in 5ml of DMSO, slowly add 0.5ml of 1,3-propylenediamine and 0.5ml of pyridine in 10ml of DMSO dropwise at 60°C. The unreacted propylenediamine was quantitatively obtained as a propylenediamine monocondensate of dexamethasone.
[0021] Get above-mentioned product and measure through proton nuclear magnetic resonance spectrum, such as figure 2 As shown, the nuclear magnetic spectrum shows that the olefin peak between 6.5-7.0ppm in the spectrum moves to the high field, and the methylene peak increased between 1.0-2.5ppm shows that the hapten is successfully synthesized.
Embodiment 2
[0022] Example 2: Dexamethasone Antigen
[0023] The dexamethasone hapten is coupled with the carrier protein to obtain the dexamethasone antigen.
[0024] 1. Immunogen preparation - synthesis of dexamethasone hapten-bovine serum albumin (BSA) conjugate
[0025] Dissolve 50mg of EDC in 2ml of water to obtain solution I; dissolve 11mg of dexamethasone hapten in 1.0ml of DMF to obtain solution II; dissolve 60mg of BSA in 3ml of 0.01mol / LPBS (pH=8.0) solution to obtain solution III; II was mixed with solution III, and added dropwise to solution I under magnetic stirring; the reaction was stirred at room temperature for 24 hours. Dialyzed with triple distilled water for 48 hours to obtain the immunogen.
[0026] 2. Coating source preparation - synthesis of dexamethasone hapten-ovalbumin (OVA) conjugate
[0027] Dissolve 15 mg of dexamethasone hapten in 1.0 ml of dimethylformamide (DMF) to obtain solution IV; take 10 μl of 50% glutaraldehyde (GA) and add it to solution IV, stir ...
Embodiment 3
[0030] Embodiment 3: Dexamethasone monoclonal antibody
[0031] 1. Preparation of dexamethasone monoclonal antibody
[0032] Animal immunization: Inject the immunogen into the body of Balb / c mice with an immunization dose of 150 μg / mouse to make them produce polyclonal antibodies.
[0033] Cell fusion and cloning: After the measurement result of mouse serum was higher, the splenocytes were taken and fused with SP2 / 0 myeloma cells at a ratio of 8:1, and the cell supernatant was measured by indirect competitive ELISA, and the positive wells were screened. Use the limited dilution method to clone the positive wells until hybridoma cell lines secreting monoclonal antibodies are obtained, and it is found that the titer of one of the hybridoma cell lines is significantly higher than that of the other hybridoma cell lines, and the dexamethasone monoclonal antibody hybridoma cell line The strain was named D-4-2, and the cell line was preserved on May 3, 2012 in the General Microbiolo...
PUM
Property | Measurement | Unit |
---|---|---|
Sensitivity | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com